Two new studies suggest that a compound derived from turmeric may have clinical promise for ischemic stroke and traumatic brain injury (TBI), both of which currently lack good therapies.
A synthetic derivative of turmeric made by scientists at the Salk Institute for Biological Studies dramatically improved the behavioral and molecular deficits seen in animal models of these conditions.
Read the complete article on acuatlanta.net

In the first trial outside of China, the National Institute on Aging currently is conducting a phase II clinical trial evaluating huperzine A in doses of 200 μg or 400 μg twice a day among patients with Alzheimer’s disease. The aims of the study are to determine if huperzine improves cognitive function, global clinical status, activities of daily living, and behavior, and to evaluate the tolerability of the supplement. Additionally, the study is investigating the relationship …

Eating purple fruits such as blueberries and drinking green tea can help ward off diseases including Alzheimer’s, Multiple Sclerosis and Parkinson’s, a University of Manchester report claims.
New research from Professor Douglas Kell, published in the journal Archives of Toxicology, has found that the majority of debilitating illnesses are in part caused by poorly-bound iron which causes the production of dangerous toxins that can react with the components of living systems.
These toxins, called hydroxyl radicals, cause degenerative diseases of many kinds in different …

Recent research has found that B vitamins appear to slow the rate of brain atrophy in elderly people with mild cognitive impairment. The study participants were randomly assigned to one of two groups, one treated with very high doses of folic acid, B6 and B12 and the other group received placebo. It was found that on average the brains of those taking the vitamin treatment shrank at a rate of 0.76 percent a year, while those taking the placebo pill had an average brain shrinkage of 1.08 percent. Researchers also discovered …